Analytical and diagnostic accuracy of the EliA™ automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 10, 2004, Pages 1161-1167

  Villalta, Danilo ^a   Tonutti, Elio ^b   Tampoia, Marilina ^c   Bizzaro, Nicola ^d   Papisch, Wolfgang ^e   Tozzoli, Renato ^d   Stella, Sergio ^a  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^c POLICLINICO   (Italy)

^d Ospedale Civile   (Italy)

^e Thermo Fisher Scientific   (United States)

Author keywords

Anti myeloperoxidase antibodies; Anti proteinase 3 antibodies; Enzyme fluoroimmunoassay; Microscopic polyangitis; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; AUTOMATION; BLOOD ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DILUTION; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; FLUOROIMMUNOASSAY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROIMMUNOASSAY; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 8344277483     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.236     Document Type: Article

References (38)

1. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990;15:517-29.
2. Hoffman GS, Specks U. Antineutrophil cytoplasmic autoantibodies. Arthritis Rheum 1998;41:1521-37.
3. Hagen EC, Ballieux BEPB, van Es LA, Daha MR, van der Woude FJ. Anti-neutrophil cytoplasmic autoantibodies (ANCA). A review of the antigens involved, the assays, the clinical and possible pathogenetic consequences. Blood 1993;81:1996-2002.
4. Wieslander J. How are antineutrophil cytoplasmic antibodies detected? Am J Kidney Dis 1991;18:154-8.
5. Ludemann J, Utech B, Gross WL. Anti-cytoplasmic antibodies in Wegener's granulomatosis are directed against proteinase 3. Adv Exp Med Biol 1991;297:141-50.
6. Falk RJ, Jennette JC. Anti neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
7. Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EAM, Kleijburgvanderkeur C, et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;32:1466-75.
8. Cohen Tervaert JW, Mulder L, Stegeman C, Elema J, Huitema M, The H, et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993;52:115-20.
9. Zhao Mh, Jones SJ, Lockwood CM. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995;99:49-56.
10. Halbwachs Mecarelli L, Nusbaum P, Noel LH, Reumax D, Erlinger S, Grunfeld JP, et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79-84.
11. Wiik A, Jensen E, Friis J. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis 1974;33:515-22.
12. Hagen EC, Daha MR, Hermans J, Andrassay K, Csernok E, Gaskin G, et al., for the EC/BCR Project for ANCA Assay Standardization. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998;53:743-53.
13. Sinico RA, Radice A, Pozzi C, Ferrario F, Ardigo G and the Italian Group of Renal Immunopathology. Diagnostic significance and antigen specificity of antineutrophil cytoplasmic antibodies in renal diseases. Nephrol Dial Transplant 1994;9:505-10.
14. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International Consensus Statement on Testing and Reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
15. Jennette JC, Falk RJ, Andrassay K, Bacon P, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
16. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder CG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group in Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996;55:116-21.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. In: van Venrooij WJ, Maini RN, editors. Manual of biological markers of disease vol A 9. Dordrecht: Kluwer Academic Publishers, 1993:1-14.
21. Nölle B, Specks U, Lüdemann J, Rohrbach M, Deremee R, Gross W. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Int Med 1989;111:28-40.
22. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol 1997;8:314-22.
23. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Int Med 1992;116:488-98.
24. Westman KWA, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, et al. Clinical evaluation of a capture ELISA for detection of proteinase 3 antineutrophil cytoplasmic antibody. Kidney Int 1998;53:1230-6.
25. Wang G, Csernok E, de Groot K, Gross WL. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). J Immunol Methods 1997;208:203-11.
26. Pollock W, Dunster K, Roland JM, Koh H, Savige J. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase. Pathology 1999; 31:38-43.
27. Csernok E, Ahluist D, Ullrich S, Gross WL. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology 2002;41:1313-7.
28. Lim LCL, Taylor J, Schmitz JL, Folds JD, Wilkman AS, Falk RJ, et al. Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology. Comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassay kits. Am J Clin Pathol 1999;111:363-9.
29. Jethwa HS, Nachman PH, Falk RJ, Jennette JC. False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. Clin Exp Immunol 2000;121:544-50.
30. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-9.
31. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36:365-71.
32. Davenport A, Lock RJ, Wallington T. Clinical significance of serial measurement of autoantibodies to neutrophil cytoplasm using a standard indirect immunofluorescence test. Am J Nephrol 1995;15:201-7.
33. Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, De Remee RA. Anticytoplasmic autoantibodies in the diagnosis and follow up of Wegener's granulomatosis. Mayo Clin Proc 1989;64:28-36.
34. Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
35. Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11.
36. Egner W, Chapel HR. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 1990;82:244-9.
37. Boomsma MM, Stegeman CA, van der Leij, Oost W, Hermans J, Kallenberg CG, et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000;43:2025-33.
38. Han Wk, Choi HK, Roth RM, McCluskey RT, Niles JC. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 2003; 63:1079-85.